Home » Topics » Briefs » Other news to note

Other news to note
RSS

Aclaris Therapeutics acquires Confluence Life Sciences

Aug. 10, 2017

Dermira to license exclusive worldwide rights to lebrikizumab

Aug. 9, 2017

PreveCeutical Medical and UniQuest sign a nonbinding letter of intent

Aug. 9, 2017

Galena Biopharma, SELLAS Life Sciences Group enter merger agreement

Aug. 9, 2017

Humanigen, new name for KaloBios

Aug. 9, 2017

Shire reports key events of second quarter 2017

Aug. 8, 2017

HitGen and Leo Pharma establish multi-year research collaboration

Aug. 7, 2017

UCB and Medical Research Council establish antibody discovery collaboration

Aug. 7, 2017

Ono Pharmaceutical updates milestones of first quarter of fiscal 2017

Aug. 7, 2017

Eisai reviews highlights of first quarter of fiscal 2017

Aug. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...